Jung Hyun Min, Phillips Brittany L, Chan Edward Kl
Department of Oral Biology, University of Florida, 1395 Center Drive, Gainesville, FL 32610, USA.
Mol Cancer. 2014 Apr 8;13:80. doi: 10.1186/1476-4598-13-80.
While microRNAs (miRNAs) are extensively studied in post-transcriptional regulation of gene expressions in many biological processes, cellular miRNA-mediated regulation of viral genes remains unclear. In particular, the interplay between human papillomavirus (HPV) genes and miRNAs and how these interactions contribute to HPV-associated cancers remain elusive.
Transient transfection of miR-375-mimic was used to compensate the loss-of-function of miR-375 in HPV-positive cancer. Regulation of oncogenic molecules and their downstream molecules via miR-375 in HPV-positive cancer was investigated using qRT-PCR, western blot, dual luciferase assay, indirect immunofluorescence analysis. All experiments were conducted at least three times to achieve statistical significance determined by Student t-test.
In this study, we demonstrated how miR-375 negatively regulates HPV16 and 18 transcripts. We also found a cellular protein, E6-associated protein (E6AP), directly regulated by miR-375. miR-375-mediated repression of HPV transcripts and E6AP elevated major tumor suppressors p53, p21, and retinoblastoma protein 1 (RB). Cooperative regulation of miR-375 targets along with the increase of tumor suppressors led to ~60% reduction of telomerase reverse transcriptase (TERT) transcription followed by ~35% decrease of telomerase activity. Furthermore, miR-375-mediated regulation of 14-3-3ζ contributes to decrease telomerase activity by altering nuclear translocation of TERT.
Taken together, miR-375-mediated suppression of multiple oncogenic components in HPV-associated carcinogenesis generates a cumulative biological response to rescue key tumor suppressors and diminish telomerase activity, which results in cell cycle arrest and cell proliferation inhibition.
虽然微小RNA(miRNA)在许多生物学过程中基因表达的转录后调控方面得到了广泛研究,但细胞miRNA介导的病毒基因调控仍不清楚。特别是,人乳头瘤病毒(HPV)基因与miRNA之间的相互作用以及这些相互作用如何导致HPV相关癌症仍不清楚。
使用miR-375模拟物的瞬时转染来补偿HPV阳性癌症中miR-375的功能丧失。通过qRT-PCR、蛋白质免疫印迹、双荧光素酶测定、间接免疫荧光分析研究了miR-375在HPV阳性癌症中对致癌分子及其下游分子的调控。所有实验至少进行三次,以达到由学生t检验确定的统计学显著性。
在本研究中,我们证明了miR-375如何负调控HPV16和18转录本。我们还发现了一种由miR-375直接调控的细胞蛋白,即E6相关蛋白(E6AP)。miR-375介导的HPV转录本和E6AP的抑制提高了主要肿瘤抑制因子p53、p21和视网膜母细胞瘤蛋白1(RB)。miR-375靶标的协同调控以及肿瘤抑制因子的增加导致端粒酶逆转录酶(TERT)转录降低约60%,随后端粒酶活性降低约35%。此外,miR-375介导的对14-3-3ζ的调控通过改变TERT的核转位有助于降低端粒酶活性。
综上所述,miR-375介导的对HPV相关致癌过程中多种致癌成分的抑制产生了累积生物学反应,以挽救关键肿瘤抑制因子并降低端粒酶活性,从而导致细胞周期停滞和细胞增殖抑制。